The most predictive biomarker for COVID-19 complications IL-6 was found 10 times decreased by the beginning of the trial (at the 30th–40th days after discharge from the hospital) as compare to its plasma content at the admission to the hospital (Figure 3a,b). The gene discussed is IL6; the disease is COVID-19.